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Loss-of-function mutations affecting the dissatisfaction (DSF) nuclear receptor alter both sexual behavior and the
sex-specific nervous system in Drosophila. As a step toward understanding the way DSF controls development and function
of the nervous system, we have analyzed the regulatory activities of the DSF protein. DSF prefers an atypical DNA half site,
AAGTCA. Wild-type DSF, but not the point mutant DSF7, monomerically binds and represses reporter constructs bearing
this site. DSF also contains an atypically long, 356-amino-acid hinge separating its DNA-binding domain (DBD) and
ligand-binding domain (LBD). The hinge contains at least two functions: a region that drastically lowers DNA-binding
efficiency in vitro, and an amino-terminal repressive domain. The DBD and LBD of DSF, along with major portions of the
hinge, are highly conserved in other insects. Ectopic expression of DSF in Drosophila imaginal discs results in
developmental disruptions in disc-derived tissues, disruptions which are largely suppressed when DSF is fused to the VP16
activation domain, consistent with a repressive role for DSF. Finally, when tethered to DNA, DSF’s hinge and LBD regions
act as strong transcriptional repressors in multiple larval and pupal tissues, including many DSF-expressing tissues. These
results suggest DSF can repress transcription in vivo, that repression is largely responsible for its ectopic expression
phenotypes, and that repression may be a key component of normal DSF function. © 2002 Elsevier Science (USA)
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The dissatisfaction (dsf) gene is required for normal male
and female sexual behavior, and for the development and
function of certain sex-specific neurons in both male and
female Drosophila melanogaster (Finley et al., 1997, 1998).
Although dsf has been shown genetically to act down-
stream of the sex-specific splicing factor Transformer
(TRA), sex-specific processing of dsf RNA has not been
observed (Finley et al., 1997, 1998). This contrasts with the
direct TRA targets doublesex and fruitless (Hedley and
Maniatis, 1991; Hoshijima et al., 1991; Heinrichs et al.,
1998). In addition, DSF protein is expressed in similar
patterns and at similar times in both males and females
(K.D.F. and M.M., unpublished results). These results sug-
gest that the point at which the sex-determination cascade
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ally, for example, through sex-specific modification of DSF
protein, control of TRA targets by DSF, or cooperative
control of genes downstream of a TRA target. Understand-
ing how DSF controls sexual behavior and nervous system
function in the fruit fly, then, likely will require a multi-
faceted approach. This would include experiments ranging
from dissection of the protein’s functional properties, to
analysis of DSF neuron projection patterns in the presence
and absence of the gene. In this paper, we examine the
transcriptional-regulatory properties of DSF.
DSF is a member of the nuclear receptor (NR) superfam-
ily, an evolutionarily conserved group of transcription fac-
tors that regulate multiple events during embryonic and
postnatal development and contribute to homeostasis in
the adult (Mangelsdorf et al., 1995). Many nuclear receptors
are multifunctional: they are site-specific transcriptional
repressors of their target genes, which can be converted to
activators of the same genes in the presence of a cognate1348. E-mail: Michael_McKeown@brown.edu.
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ligand. Some NRs, such as DSF, are orphans, having no
known ligand. Some of these may lack a ligand, while
others may have ligands that have yet to be discovered
(Mangelsdorf and Evans, 1995; Kliewer et al., 1999). In
addition, some NRs can be activated for transcription,
independent of ligand, via modifications such as phosphor-
ylation (Hammer et al., 1999).
In this paper, we investigate the molecular and in vivo
functional properties of DSF. This includes examination
and characterization of DSF functional domains both bio-
chemically and in cell culture. We then verify some of these
properties in vivo and analyze the biological consequences
of altered DSF expression. As part of this, we show that DSF
binds DNA sites with an AAGTCA sequence both in vitro
and in cultured cells. DSF DNA binding is modified by
residues within DSF’s hinge domain, which connects the
DNA binding and ligand binding domains. We demonstrate
that the LBD contains a strong repressive domain and that
the hinge contains a repressive domain subject to modula-
tion by other portions of the hinge. In vivo we show that
misexpression of DSF has substantial consequences for
development and further show that some of these pheno-
types are ameliorated by inclusion of a constitutive activat-
ing domain, thereby implicating functional repression in
vivo as a cause of the DSF misexpression phenotypes.
Finally, we use direct tests of coexpression with reporter
genes to demonstrate that DSF repressive domains function
in vivo as well as in culture.
MATERIALS AND METHODS
Fly Stocks
Drosophila stocks were grown on standard cornmeal, molasses,
yeast, and agar medium at room temperature. Transformation was
achieved in a w1118 genetic background, using standard procedures
(Rubin and Spradling, 1982). GAL4 drivers were obtained from the
Bloomington Drosophila Stock Center at Indiana University, with
the exception of ALK-GAL4, which was a gift from Ruth Palmer,
and dsf1.8-GAL4, which was described previously (Finley et al.,
1998). UAS-SVP1 was a gift from Yasushi Hiromi and was de-
scribed previously (Kramer et al., 1995).
DSF Constructs
Mammalian expression vectors were constructed by using
pcDNA3-FLAG (“pcFL”), pCMX-GAL4, or pCMX-VP16. pcFL is a
derivative of pcDNA3 (Invitrogen), containing a FLAG epitope
tag-encoding sequence at the 5 end of the multiple cloning site.
pCMX-GAL4 and pCMX-VP16 have been previously described
(Tsai et al., 1999). All three vectors allow either in vitro
transcription/translation (via T7 RNA polymerase-based TNT kit;
Promega) or expression in mammalian cells, under the control of
the CMV promoter. GAL4-dependent expression in Drosophila
utilized the pUAST vector (Brand and Perrimon, 1993).
DSF Deletion Mutant Construction
Carboxy-terminal deletion mutants were generated by PCR,
using a 5 primer containing an EcoRI site followed by a Kozak-
optimized initiation sequence with an in-frame ATG codon, in the
reading frame GAATTCACCACCATG, followed by at least 15
nucleotides of downstream sequence. At the 3 end, a HindIII site
was introduced 3 to the terminal codon. PCR products were cloned
first into pBS-SK and fully sequenced on both strands. Except as
noted, constructs were then shuttled into pcFL as BamHI–SalI
fragments, into CMX-GAL4 as EcoRI–SalI fragments, into CMX-
VP16 as XbaI–SalI fragments, and into the BamHI and XhoI sites of
pGEX-KG as BamHI–SalI fragments.
Site-Directed Mutagenesis
DSF7 cDNA was reproduced by using a procedure similar to
Stratagene’s Quick-Change Mutagenesis Kit. Complementary
sense and antisense primers, each containing the dsf7 mutation,
were used in a Pfu-based PCR, using pBS-DSF1–102 as a template.
Template was removed by digesting the PCR for 1 h with DpnI, and
then the entire reaction was used to transform XL2-Blue bacteria.
Colonies were picked and analyzed for the presence of the induced
mutation by sequencing. A positive cDNA was then recloned into
pcFL, CMX-GAL4, and CMX-VP16.
Cloning DSF from Other Invertebrate Species
A full-length Drosophila virilis genomic clone of dsf was ob-
tained by low-stringency hybridization of D. melanogaster dsf
DBD sequences with a D. virilis genomic library. Clones positive
for hybridization to D. melanogaster dsf’s DBD were retained for
further analysis, and all appeared to contain similar inserts by
restriction mapping. Sequencing of the entire D. virilis dsf-
encoding region revealed an apparent intron–exon structure iden-
tical to that of D. melanogaster dsf. A clone containing the D.
virilis dsf DBD-encoding sequences was used to screen for more
downstream sequence, eventually resulting in clones spanning the
entire coding sequence of D. virilis dsf, enabling the theoretical
translation of the protein sequence shown in Figs. 3B and 3C.
For Manduca sexta dsf, a small portion of the gene was cloned by
PCR, using genomic DNA as a template and degenerate oligonucleo-
tides based on DBD regions conserved between dsf and tll. First round
primers: Forward 5-TG(C/T)AA(A/G)GTNTG(C/T)GGNGA-3; Re-
verse 5-(G/C)C(A/G)TC(C/T)TT(A/G)TTCATNGC-3. Two microli-
ters of the first round product was used in a second round of PCR,
using the nested primers: Forward 5-(G/C)NGGNAA(A/G)CA(C/
T)TA(C/T)GGN-3; Reverse 5-CG(A/G)TGNGT(C/T)TT(A/G)TC-
NAC-3. All products were cloned into pCR-Script SK and se-
quenced. The insert of a clone encoding DSF-like P- and D-box regions
and an intron was used to screen a Manduca genomic library at high
stringency. A single partial M. sexta dsf clone which truncates in the
intron within DSF’s T-box, was obtained.
Electrophoretic Mobility Shift Assays (EMSAs)
Analysis of DNA binding was performed using EMSA, essen-
tially as described (Tsai et al., 1999). Proteins were translated in
vitro using the TNT T7 coupled transcription–translation reticu-
locyte lysate system (Promega). All oligonucleotides used con-
tained a 5 AGCT overhang, which was labeled by filling in with
cold dATP, dGTP, and dTTP and [32P]dCTP, using Klenow. Binding
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reactions were carried out for 30 min on ice, using 2 l protein and
50,000 cpm oligonucleotide, in a 20-l total volume, containing
1 binding buffer [final concentration: 4 mM Tris, pH 7.5; 0.05 mM
EDTA; 5% glycerol; 0.1% NP-40; 100 mM KCl; 100 M DTT, and
30 ng/l poly(dI  dC/dI  dC)]. Binding reactions were loaded and
run on prerun 6% PAGE/0.25X TBE gels at 100 V for 2 h, dried onto
3 MM paper, and exposed to autoradiographic film overnight.
Transient Transfections
All transfections were performed in CV-1 (monkey kidney) cells,
essentially as described (Tsai et al., 1999). Transfected cells were
incubated at 37°C for 36–48 h, harvested, and assayed for luciferase
(experimental) and -galactosidase (cotransfection control) activ-
ity. Luciferase activity is divided by -galactosidase activity for
each well, to give a unitless measure of activity. All transfections
were performed in triplicate (three wells) and repeated at least three
separate times. Transfection results are expressed as the mean 
SEM for three wells.
RESULTS
DSF Binds AAGTCA-Containing Sites in Vitro
Due to the similarity in the DNA-binding domains of
DSF and vertebrate Tailless (TLX) proteins (Finley et al.,
1998), we inferred that DSF might share TLX’s preference
for the atypical half-site, AAGTCA, present in elements
such as the Drosophila Tailless (dTLL) binding site in the
Kru¨ppel promoter (Hoch et al., 1992). EMSA analysis re-
veals this to be the case. In vitro translated DSF DBD
prefers an AAGTCA-containing site (binding shown in Fig.
1) to one with the more common core AGGTCA (DR1.5G,
not shown), which is bound severalfold less well than the
weakly binding DR1.5L (Fig. 1B). Similar results are seen
with full-length DSF protein (not shown). For clarity, we
present data using the DSF DBD since full-length DSF
comigrates with a reticulocyte lysate-derived nonspecific
band (Fig. 2B, and data not shown) and since full-length DSF
binds DNA more weakly (see below).
The DSF DBD displays robust binding to a series of direct
(DR) and inverted (IR) repeats of AAGTCA half-sites, sepa-
rated by zero to four nucleotides (listed in Fig. 1D) with
mobility suggesting monomer binding (Fig. 1A). The IR0
and IR1 sites bind less well, and dimers form on DR2 (see
below). The differences in monomer binding to different
sites suggest that sequences flanking the half site contrib-
ute to binding.
To test this possibility, we examined monomer binding
to variants of the DR1 oligo (Fig. 1B). DSF binds strongly to
both the original Kru¨ppel half site and to the right-hand
DR1 half-site (DR1.5R; Fig. 1B, lanes 1 and 2). In contrast,
relatively poor binding is observed on the left-hand half-site
(DR1.5L; Fig. 1B, lane 3), demonstrating the importance of
flanking sequences. Selectively varying only the nucleo-
tides 5 or 3 to the half-site shows that whenever the 3
sequences specific to DR1.5L are present, as in DR1.5L and
DR1.5B (Fig. 1B, lanes 3 and 5), binding is relatively poor.
Thus, in addition to the observed preference for an
AAGTCA half-site, significant determinants of DSF bind-
ing lie 3 to the half-site. This contrasts with the mono-
meric recognition sequences of the nuclear receptors
ROR1 and SF-1, which require specific nucleotides 5,
rather than 3, to the half-site (Gigue`re et al., 1995; Ito et al.,
2000). We cannot exclude the possibility that additional
determinants of DSF binding might also lie 5 to the
half-site.
DSF’s DBD forms dimeric complexes on a DR2 element
(Fig. 1A). When DR2 is incubated with increasing amounts
of DSF1–102 protein, over a 25-fold range, binding goes from
predominantly monomeric to predominantly dimeric (Fig.
1C, lanes 1–3). This indicates that DSF’s DBD is forming at
least semicooperative dimers on this site, although dimer-
ization is not overwhelmingly favored. Both DSF bands are
supershifted by anti-FLAG antibodies, demonstrating the
presence of DSF in both complexes (Fig. 1C, lanes 4 and 5).
This dimeric binding is, however, probably not essential for
DSF function (see below).
DSF Is a Site-Specific Transcriptional Repressor in
Mammalian Cells
To test if and how DSF regulates transcription through its in
vitro binding sites, an expression vector encoding full-length
DSF was cotransfected into CV-1 cells with vectors in which
luciferase expression is controlled by multimerized DSF-
binding sites (4DR1 or 7DR2). Figure 1E shows that DSF
expression decreased reporter activity relative to cotransfec-
tion with empty expression vector, from either the DR1 or
DR2 reporters, but not from an Ecdysone Receptor-responsive
reporter (6[hsp27 EcRE]-tk-luciferase), to which it does not
bind in vitro (data not shown). Thus, DSF acts as a site-specific
transcriptional repressor, at least in the cell type tested.
To verify DNA binding in our cellular system, we fused
the VP16 activation domain to the amino terminus of DSF
and assayed its activating ability in mammalian cells (CV-
1). Even in the presence of its repressive domain, this
VP16-conjugated protein activates both the DR1 and DR2
reporters, but not the EcRE reporter (Fig. 1F). This confirms
the ability of DSF to bind the AAGTCA sites in a cellular
context and to discriminate against other nuclear receptor
binding elements. We also note here that, in the case both
of repression and of the VP16-mediated activation, DSF did
not function significantly better on the DR2-based reporter
than on the DR1-based one, this despite the higher numbers
of binding sites in 7DR2 than is 5DR1. From this we
conclude that, although DSF can dimerize on the DR2 site,
doing so does not appreciably increase DSF’s activity and is
therefore unlikely to be mechanistically favored in vivo.
DSF’s Ligand-Binding Domain and Hinge Region
Both Contain Repressive Capacity
To map functional domains within DSF, we fused portions
of DSF to the DNA-binding domain of the yeast GAL4
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FIG. 1. (A–C) DSF preferentially binds extended AAGTCA half-sites. EMSA analyses using in vitro translated proteins and 32P-labeled
oligonucleotides are shown. In this and following figures, “F” prefix indicates FLAG epitope tag; “FL” subscript denotes “full length.” (A)
DSF binds a variety of direct repeats and inverted repeats of AAGTCA half-sites. FLAG epitope-tagged DSF DNA-binding domain
(F-DSF1–102) binds the AAGTCA site (“Half site”) found in the Kru¨ppel enhancer (Hoch et al., 1992), as well as oligos containing direct (DR)
and inverted repeats (IR) of this site (oligos listed in Fig. 1D). Additionally, multiple shifted complexes are observed on DR2. All lanes shown
were from the same gel. DSFd indicates a band corresponding to dimer binding; DSFm indicates monomer binding, as seen on the half-site
oligo. (B) Binding site specificity extends beyond the half-site. Substitutions in the nucleotides flanking the half-site (DR1.5R, -L, -A, and
-B) or within the half-site alter the binding affinity of F-DSF1–102. All lanes shown were from the same gel. Conversion of the AAGTCA
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transcription factor. Full-length DSF (DSFFL) fused to GAL4
represses transcription from a UAS-controlled (GAL4-binding)
reporter (Fig. 1G). Subdivision of DSF into its three main parts
(DBD, hinge, LBD) maps repressive activity to DSF’s LBD
(GAL4-DSF487–693), although modest repression also is con-
ferred by the DBD (Fig. 1G). The apparent repression by the
DSF DBD may be artefactual, as the strongly binding DSF1–102
fragment may draw the GAL4 DBD toward DSF-binding sites
in the genome, and away from the reporter construct. The
full-length hinge (DSF172–463) does not repress.
Surprisingly, division of the 356-amino-acid hinge into
four similarly sized pieces reveals that the amino-terminal
portion contains a second repressive domain, which is
apparently silent in the context of the full-length hinge.
When fused to GAL4, DSF amino acids 172 through 265
repress activity from a GAL4-dependent reporter (Fig. 1H).
No significant repressive or activating function is detect-
able in other hinge portions (Fig. 1H). Since no compensa-
tory activating domains were revealed in downstream hinge
regions, these data suggest a model in which the carboxy-
terminal regions of the hinge inhibit repression by the
amino-terminal regions, perhaps by preventing access to
corepressive factors. We label this repressive activity in
amino acids 172–265 “Repressive Function 2,” or RF2,
where RF1 resides in the LBD.
DSF’s Hinge Region Interferes with DNA Binding
The analysis of DSF DNA-binding activity in Fig. 1 used
the isolated DBD, which binds DNA well. Full-length DSF
similarly prefers AAGTCA direct repeats, but the level of
binding by in vitro-synthesized or bacterially produced
protein is substantially reduced. We suspected that amino
acid motifs downstream of the DBD, perhaps in the exten-
sive hinge region, might interfere with DNA binding. To
test this, we created a series of internal or carboxy-terminal
deletions of DSF (Fig. 2A). The binding observed with in
vitro translated proteins (Fig. 2B) was adjusted for expres-
sion level (Fig. 2C), and the relative binding strength of each
deletion mutant is summarized in Fig. 2A.
Maximal binding was observed with the shortest protein,
DSF1–102, which terminates immediately following the A-box,
the carboxy-terminal end of the DBD (Fig. 2B, lane 2). The
polyhistidine/polyalanine region immediately following the
DBD, in DSF1–172, dramatically reduced binding efficiency (Fig.
2B, lane 4), similar to the observed effects of poly(amino acid)
repeats on binding by the ESX1 homeoprotein (Yan et al.,
2000). Additional regions in the hinge also appear to interfere
with DBD activity. Relative binding declines in DSF1–243 and
drops below the limit of detection with DSF1–428 (Fig. 2B, lanes
5 and 6). This suggests that additional regions inhibiting DNA
binding lie between amino acids 172 and 428. Consistent with
these results, a deletion removing the region from the polyhis/
polyala motif through amino acid 322, in DSF102–322, dramati-
cally improved binding relative to full-length DSF (Fig. 2B,
lanes 8 and 10; note that DSFFL comigrates with the major
nonspecific band present in the reticulocyte lysate). Together,
these data suggest that the polyalanine/polyhistidine repeat
region (amino acids 103–162) and at least one region within
amino acids 172–488 inhibit binding of the DBD to the sites
tested.
Exposed RF2 Is Functional on DSF Binding Sites
We next tested the intrinsic repressive capacity of these
proteins by direct fusion to the GAL4 DNA-binding domain
(Fig. 2D). All proteins tested are repressive to some degree.
Notably, both GAL4-DSF1–172 and GAL4-DSF1–243 are stron-
ger repressors than GAL4-DSF1–102 (Fig. 2D), extending the
RF2 repressive domain further N-terminally, to amino acids
102–265, and showing that RF2 is still functional in the
presence of the DSF DBD. This activity is reduced when
additional C-terminal hinge sequence is present, as in
GAL4-DSF1–428 (Fig. 2D), consistent with the results ob-
served in Fig. 1H, when these regions of the hinge were
fused directly to GAL4. Adding the primary repressive
domain found in the LBD, in GAL4-DSFFL, results in strong
repression.
In an attempt to analyze DNA-binding properties in a
cellular context, we N-terminally tagged each DSF deletion
half-site in DR1.5R to AGGTCA (in DR1.5G, not shown) results in severalfold lower binding than with DR1.5L. (C) The isolated DSF DBD
(F-DSF1–102) forms dimers on DR2. Increasing amounts of in vitro translation mix (0.2, 1, and 5 l, lanes 1–3) result in increased intensity
of the upper (dimer) band. Both DSF bands (using 2 l translation mix) can be supershifted with anti-FLAG antibodies (lane 5). DSFss,
super-shifted DSF band. (D) Sequences of oligos used in (A–C). Shading indicates nucleotide changes relative to DR1.5R. (E–H) DSF
specifically represses AAGTCA-containing reporters. All data are from transient transfections in CV-1 cells. A mean  SEM of three
individual transfections is shown in each case. (E) Full-length FLAG-tagged DSF (F-DSF) reduces activity from a 4xDR1-tk-luciferase
reporter (left) and a 7xDR2-tk-luciferase reporter (center), relative to empty FLAG expression vector, but shows no effect on a 6x(hsp27
EcRE)-tk-luciferase reporter (right). (F) A VP16-fused version of DSF activates the same reporters repressed in (E). (G) A repressive domain
in DSF maps to the LBD (amino acids 487 through 693). Portions of DSF were fused to the GAL4 DNA-binding domain, and activity
assessed relative to GAL4 DBD alone by cotransfecting with a GAL4-dependent (4xMH100 GAL4E-tk-luciferase) reporter. DSF’s LBD
reduces reporter activity substantially. Modest repressive activity is present in the DBD alone (GAL4-DSF1–102), but none is detectable in the
full-length hinge (GAL4-DSF172–463). (H) DSF’s hinge contains an amino-terminal repressive motif, masked in the full-length hinge. Fusion
of pieces of DSF’s hinge to GAL4 reveals repressive activity in amino acids 172–265, although this repression does not appear functional
when more C-terminal hinge residues are present (as in GAL4-DSF172–463).
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mutant protein with the VP16 activation domain and tested
activation of DSF site reporters. All DSF deletion mutants,
including those with poor in vitro binding, such as DSF1–428,
showed some activating ability on a 4xDR1 reporter (Fig.
2E). No activation was detected on an empty tk-luciferase
reporter (data not shown). The absolute values of activation
in this assay are largely irrelevant, as they reflect a complex
combination of both the protein’s overall DNA-binding
affinity and competing repression by non-DBD portions of
the protein. The site-specific activation of DSF site report-
FIG. 2. DSF’s hinge region interferes with DNA binding. (A) DNA binding activity by DSF deletion mutant proteins. The structures of
wild-type and deletion mutant variant proteins are diagrammed. Relative binding strength is summarized, based on relative level of shifted
target (2B) vs relative level of protein (2C).  represents the strongest binding;  represents no observed binding. (B) EMSA using a
DR1.5A oligonucleotide (Fig. 1D) as target and in vitro translated, C-terminally, or internally deleted DSF proteins. Two microliters of each
translation mix was used in each lane. Lane 1 shows the background binding due to reticulocyte lysate programmed with an empty FLAG
expression vector. Labels on either side of the gel indicate the positions of specific shifted bands. Asterisks indicate nonspecific bands. This
gel was overexposed to allow detection of weak bands, such as that of F-DSF172–322. Full-length DSF comigrates with the second background
band from the top (data not shown). No specific band shifts are detectable for F-DSF1–1027 , F-DSF1–428, or F-DSF1–526. (C) Anti-FLAG
immunoblot using 5 l of each translation mix used in (B). Both F-DSF1–102 and F-DSF1–1027 migrate at the position marked to the left of the
gel, but are not visible in this short exposure. On longer exposure, they give signals of equivalent intensity (data not shown). (D–F) Transient
transfections in CV-1 cells. (D) GAL4-conjugated, C-terminally deleted DSF proteins lacking the LBD are still intrinsically repressive,
relative to GAL4 DBD. (E) VP16-fused versions of DSF deletion mutant proteins that bind DNA poorly in vitro can still activate a
4xDR1-tk-luciferase reporter. This site-specific activation indicates that these proteins all bind the DR1 site, albeit at a level below
detectability by EMSA using in vitro translated protein. (F) With the exception of F-DSF1–102 and F-DSF1–428, DSF deletion mutant proteins
all repress activity of a 4xDR1-tk-luciferase reporter, revealing both DNA-binding and functional repressive activity in a cellular context.
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ers does, however, allow us to answer the binary question of
whether or not these proteins can specifically bind DSF
sites. For proteins whose binding is otherwise barely or
even not detectable by EMSA, such as DSFFL and DSF1–428,
the answer this sensitive assay provides is clearly yes.
Finally, we tested whether DSF deletion mutant proteins,
which appeared intrinsically repressive as GAL4 fusions,
could bind and repress transcription on a 4xDR1 reporter
(Fig. 2F). This overall repressive activity reflects a combi-
nation of both binding strength (Fig. 2A), and the intrinsic
repressive capacity (Fig. 2D). Thus, a weakly binding,
weakly repressive protein such as F-DSF1–428 does not de-
tectably repress the reporter, whereas F-DSF1–243, which
both binds and represses to a greater degree, represses the
4xDR1 reporter quite well. Thus, the RF2 repressive do-
main appears functional on DSF-binding sites, at least when
carboxy-terminal hinge sequences are removed. Note that
F-DSF102–322 and F-DSF172–322, which remove all or part of
RF2, still repress. This indicates the function of the repres-
sive domain within the LBD.
Conservation of dsf in Insects and Analysis of DSF
Mutant Proteins
Given the apparent functional importance of the various
regions of DSF, we would expect these domains—the atypi-
cal DBD, the extensive hinge, and the LBD—to be function-
ally conserved if they are required in vivo. We have isolated
dsf genomic sequence from two other insect species: com-
plete sequence from the approximately 60 million years-
divergent fly D. virilis (O’Neill and Belote, 1992), and
sequence from two DBD exons from the lepidopteran M.
sexta. Intron–exon boundaries are perfectly conserved in
both cases, and a high level of amino acid identity is evident
(Fig. 3). D. melanogaster DSF (dmDSF) and D. virilis DSF
(dvDSF) are completely identical within their DBDs, and
Manduca DSF (msDSF) has only a single nonconservative
substitution in this region (Fig. 3B). dmDSF and dvDSF are
also highly homologous within their LBDs, showing 97%
amino acid identity. We would expect both the DBD and
the LBD to function highly similarly in both species.
The hinge region shows both conservation and diver-
gence. Overall length (356 amino acids in dmDSF, 384
amino acids in dvDSF) and amino acid content are con-
served. Sequence identity is significant at 59%, lower than
in the DBD or LBD, although lengthy runs of perfect
conservation are evident (Fig. 3C). This includes the
polyhistidine/polyalanine repeat region C-terminal to the
DBD, as well as more complex sequences.
Analysis of the dsf7 point-mutant allele, which produces
phenotypes indistinguishable from those of complete
genomic nulls (Finley et al., 1998), reinforces the impor-
tance of the DBD in DSF function. The dsf7 mutation
introduces a histidine to tyrosine conversion (GKHYG to
GKYYG) in DSF’s DNA-binding domain, just amino-
terminal to the P-box (Finley et al., 1998), at a position
conserved in all other nuclear receptors. To analyze the
effects of this mutation on DNA binding, we generated a
DSF7 mutant protein containing just the DBD (amino acids
1–102) and compared its activity to the wild-type DBD.
Although wild-type DSF1–102 binds well, the single amino
acid change in the DSF1–1027 variant renders DNA binding
undetectable by EMSA (Fig. 2B, lane 3).
As the in vitro translated versions of both proteins are
barely detectable by Western blot (Fig. 2C), we also com-
pared the ability of transiently transfected VP16-DSF1–102
and mutant VP16-DSF1–1027 proteins to activate DSF site-
containing reporters. Activation of a 4xDR1 reporter by
VP16-DSF1–1027 is detectable, with reporter activity 2- to
3-fold greater than with VP16 alone, but reaches a mere
2.9% of the activity achieved with the wild-type VP16-
DSF1–102 protein (Fig. 3D). There is no detectable difference
in intrinsic repressive capacity between the two proteins
(Fig. 3E). Consistent with these results, a FLAG-tagged
version of the mutant protein is unable to repress a 4xDR1
reporter (Fig. 3F). Western analysis of the transiently trans-
fected FLAG-tagged proteins reveals that the DSF7 mutant
protein accumulates to levels approximately 6-fold lower
than the wild-type version (data not shown). These differ-
ences in protein levels are not sufficient to account for
either the dramatic difference in binding in vitro (Fig. 2A) or
the greater than 30-fold difference in VP16-mediated acti-
vation of DSF reporters (Fig. 3D). Thus, the DSF7 mutant
protein is still marginally capable of binding DNA, but its
affinity is severely reduced.
Ectopic DSF Expression Is Toxic in Vivo
We next sought to examine the in vivo properties of DSF
in developing Drosophila. Since dsf normally has a limited
expression pattern, and natural DSF targets are not yet
known, a gain-of-function analysis was employed. We used
the GAL4/UAS system (Brand and Perrimon, 1993) to drive
tissue-specific expression of either full-length DSF or VP16-
DSFFL. Tissue-specific expression is controlled by a series of
Drosophila enhancers directing production of the yeast
GAL4 transcription factor, which then activates expression
of UAS-regulated variants of DSF. If the gain-of-function
phenotypes observed with DSF result largely from repres-
sion by DSF, then converting DSF to a moderate constitu-
tive activator by fusing it to the VP16 activation domain
(Fig. 1F) should ameliorate these phenotypes. Conversely, if
activation makes a major contribution to the observed
phenotype, adding another activation domain should make
DSF a more potent activator, thereby increasing the pheno-
typic severity.
In most cases, expressing DSF outside of the small
population of neurons that normally express it, especially
in embryos and larvae, results in lethality (Table 1). General
misexpression of DSF throughout the embryo using an
Actin5C-GAL4 driver is embryonic lethal, as is expression
in the patterns of elav and hairy. This is not simply the
result of nuclear receptor misexpression, as expression of
the moderately similar nuclear receptor seven-up (SVP1)
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FIG. 3. Conservation of the dsf gene in other invertebrate species and analysis of DSF point-mutant protein function. (A) Alignment of
D. melanogaster DSF (dmDSF), D. virilis DSF (dvDSF), and a partial M. sexta DSF (msDSF) illustrates the conservation of DSF’s DBD and
LBD sequences across diverse insect species. The percent amino acid identity with dmDSF is indicated within each functional domain. (B)
Alignment of amino-terminal dmDSF, dvDSF, and msDSF sequences. Asterisks indicate intron positions, which are perfectly conserved;
dashes indicate amino acid identity; and the period indicates the end of available msDSF sequence, which terminates within the T-box
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shows no such toxicity, except when driven by distalless-
GAL4 (Table 1). For these drivers yielding early (embryonic
or first instar larval) lethality with UAS-DSF, similar times
of death are observed with UAS-VP16-DSF (Table 1). It is
unclear whether DSF is activating or repressing in these
situations, although it is conceivable that both strong
activation and strong repression of target genes could del-
eteriously affect the expressing tissue, and result in embry-
onic death. We do not know if the specific cellular or
organismal causes of death are similar or different in these
cases, as the lethality was not investigated further.
Instead, we directed our attention to drivers that allowed
survival to pupal or adult stages when misexpressing DSF.
These include ALK-GAL4, dpp-GAL4, and GMR-GAL4
(Table 1). Focusing on these stages allowed more detailed
analysis of phenotypes, since the animals are larger and
contain a greater variety of differentiated cell types. Addi-
tionally, these drivers allow us to examine DSF function
during pupation, a time during which adult sexual behavior
is being programmed (Belote and Baker, 1987). Interestingly,
these drivers produce different phenotypes when UAS-
VP16-DSF is used, as opposed to UAS-DSF. This suggests
that, at least in the regions in which these latter three
drivers are expressed, DSF might act as a repressor in vivo.
To investigate this more thoroughly, we examined dpp-
GAL4 and GMR-GAL4 in greater detail.
Repression by Ectopic DSF Interferes with Distal
Appendage Development
dpp-GAL4 drives ectopic expression in a narrow stripe
along the anterior–posterior boundary of imaginal discs.
DSF expression in this pattern allows survival to adulthood,
but causes significant patterning defects in distal regions of
adult appendages (Figs. 4A–4F). All adults misexpressing
full-length DSF lack aristae, have poorly developed,
crumpled wings, and display posterior expansion of the eye
(Table 1). Additional defects are apparent in the legs: all
segments distal to the tibia are severely truncated or miss-
ing (Figs. 4A and 4B). The leg phenotypes are 100% pen-
etrant across all UAS-F-DSFFL lines tested, although the
expressivity (phenotypic strength) varies, often between
legs on a single fly. The range of dysmorphology observed
with UAS-F-DSFFL is shown in Figs. 4A (moderate) and 4B
intron. (C) dmDSF and dvDSF hinge sequences share large regions of complete identity. Identical amino acids are shaded. D–F: (D) Testing
DNA binding via site-specific reporter activation by VP16 fusions, (E) intrinsic repressive capacity, as judged by repression of a
GAL4-dependent reporter, and (F) overall repression on a DR1 reporter, by a DSF DBD carrying the dsf7 mutation (DSF1–1027 ) vs wild-type DSF
DBD (DSF1–102) and full-length DSF (DSFFL). All data are representative transient transfections into CV-1 cells, and represent the mean of
three individually transfected wells.
TABLE 1
Summary of GAL4:UAS Misexpression Phenotypes
GAL4 driver
UAS construct (number of lines tested)
UAS-F-DSFFL (5) UAS-VP16-DSFFL (5) UAS-SVP1 (1)
Act5C-GAL4 Embryonic lethal (E.L.) E.L. Viable, fertile.
dll-GAL4 E.L. E.L. E.L.
elav-GAL4 E.L./First-instar lethal. E.L./First-instar lethal. Viable, fertile.
h-GAL4 E.L. L1 lethal. L1 lethal.
ALK-GAL4 Wandering third instar/
prepupal/pupal lethal; only
the anterior half of the
adult develops in the pupal
case (cryptocephalic).
Pharate adult lethal; crooked hind
legs, foreshortened middle legs.
Viable, fertile.
dpp-GAL4 Some pupal lethality. Adults
lack aristae and distal leg
segments; have crumpled
wings, cleft nota, posterior
expansion of the eye field.
Viable, fertile; no detectable defects. Viable, fertile; no
detectable defects.
GMR-GAL4 Incompletely pharate adult
lethal; loss of eye pigment,
bristles; rough eye surface;
necroses.
Viable, fertile; moderate ommatidial
disruption, bristle and pigment
loss.
Viable, fertile; Rough eyes,
moderate ommatidial
disorganization.
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FIG. 4. Ectopic expression effects of DSF result largely from repression. (A–F) Adult distal structures are lost after ectopically expressing
DSF in a dpp-driven pattern in imaginal discs. Legs from adult flies carrying single copies of dpp-GAL4 and the UAS transgene marked are
shown. Segments are labeled in the leg in (C) which is indistinguishable from wild-type. Arrowhead indicates femur–tibia joint; arrow
marks tibia–tarsal joint. Proximal (body) is to the left, distal to the right. (A, B) Range of phenotypes observed in flies carrying UAS-F-DSFFL.
All show loss of tarsal claws and near-complete loss of tarsal segments. More extremely affected legs also have reduction in femur and tibial
length, thickening and/or twisting of femur and tibia, and tufts of bristles. Similar results observed with: (D) F-DSF172–322 and (E) F-DSF1–243.
(C) Fusion of the VP16 activation domain to DSF eliminates ectopic DSF effects. Normal-appearing femur (f), tibia (tb), and tarsal segments
(I–V) are evident. (F) VP16-DSF1–172, which powerfully activates DSF reporters, profoundly disrupts leg structure, resulting in a severely
distorted limb with ectopic structures emerging from multiple positions along the femur/tibia. (G) Lethality of GMR-GAL4 driving
UAS-based DSF derivatives. Lethality is measured as percentage of pharate adults which fail to eclose. “Line” refers to independent UAS
transgene insertions. (H–M) Misexpression of DSF posterior to the morphogenetic furrow using GMR-GAL4 alters eye structure. All flies
shown are 6- to 7-day-old adult females, except as noted, containing single copies of GMR-GAL4 and a UAS-transgenic construct. Anterior
is to the left, and dorsal is up. (H) A normal-appearing eye (UAS-membrane targeted GFP) from a one-day-old female. Red pigment and an
ordered array of ommatidia are apparent. (I) UAS-F-DSFFL3A. A substantial loss of pigment and ommatidial structure is apparent. Arrow
indicates a necrotic patch, seen in approximately 40% of flies misexpressing full-length DSF. Arrowheads indicate scattered remaining
bristles. (J) UAS-VP16-DSFFL3A. A weak-to-moderate phenotype (compare to I). Reduced pigmentation, slight ommatidial disorganization.
A notable difference is the complete loss of bristles below the dorsal–ventral equator (arrow). (K) UAS-F-DSF172–3223A. Note the similarity
in pigmentation, bristle loss, and size to full-length DSF in (I). A small necrotic patch is also visible. (L) UAS-F-DSF1–2433A. A weak
phenotype, with modest pigmentation, bristle and ommatidial defects.
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(strong). All legs show at least the loss of tarsal segments
observed in Fig. 4A, while others show additional defects in
the femur and/or tibia, as in Fig. 4B. Similar phenotypes are
evident using UAS constructs containing DSF deletion
mutants that repress in vitro, such as F-DSF172–322 (Fig. 4D)
and F-DSF1–243 (Fig. 4E).
Since all of the constructs causing loss of distal leg
structures, including those lacking an LBD, repress DSF
reporters in tissue culture (Fig. 2F), we would predict that
DSF appears to be acting as a repressor in cells expressing
dpp-GAL4. Consistent with this, balancing the LBD’s re-
pression with the VP16 activation domain, as in the weakly
activating VP16-DSFFL, produces no discernible phenotype
when driven by dpp-GAL4 (Table 1; Fig. 4C). The legs,
wings, eyes, aristae, and nota of all flies expressing VP16-
DSFFL are indistinguishable from those of wild-type flies.
The lack of detectable phenotypes with UAS-VP16-DSFFL in
these crosses cannot be due to inability of the transgene to
be expressed, since the same lines produce phenotypes with
other drivers (Table 1; Fig. 4J). This suggests that, under
dpp-GAL4 control, the VP16 activation domain counterbal-
ances the repressive activity of full-length DSF.
As a further test, we asked whether a stronger activator
would not merely balance the putative repressive DSF
phenotypes, but generate different phenotypes. Ectopic ex-
pression of a much more strongly activating form of DSF,
VP16-DSF1–172 (Fig. 2E), produces some phenotypes which
appear to be the opposite of those seen with F-DSFFL (Fig.
4F). The legs are once again grossly deformed, but instead of
complete absence of tarsal segments, multiple distal-
appearing segments are present. Additionally, duplications
are seen in the third antennal segment (data not shown).
Instead of the expanded eye fields seen with F-DSFFL and the
other repressive constructs, flies receiving VP16-DSF1–172,
have small, rough eyes, or in some cases, a complete loss of
eye tissue (data not shown). We therefore suggest that much
of the observed dpp-GAL4-driven toxicity of UAS-F-DSFFL
results from repression by DSF.
Misexpression of DSF Disrupts the Morphology of
the Developing Eye
To continue analysis of ectopic DSF expression, we next
chose a tissue in which dsf is normally expressed: the
developing Drosophila eye disc. Differentiating photorecep-
tors R1 through R7 normally express DSF (K. D. Finley and
M. McKeown, unpublished results). To drive additional
expression in the eye, we used GMR-GAL4, which is active
in all cells posterior to the morphogenetic furrow, including
FIG. 5. DSF’s hinge and LBD regions repress reporter activity in
vivo in dsf-producing cells. (A) A generalized overview of the
combined expression/reporter system. The 1.8-kb dsf enhancer
drives full-length GAL4 expression, which then activates both
UAS-GFP and one other UAS transgene: either UAS-F-DSFLBD (B, D,
F, H), as a neutral control for additional UAS sequences, or
UAS-GAL4-DSFHL (C, E, G, I). The latter transgene produces a
chimeric GAL4DBD-DSFHL protein, which can then act either posi-
tively or negatively on the UAS-GFP reporter and on its own
expression. Membrane-targeted GFP (UAS-mGFP) was used exclu-
sively. (B–E) Salivary glands (B, C) or nervous systems (D, E) from
wandering stage third-instar larvae. Anterior is to the left in (D, E).
(F–I) Developing ventral nerve cords (F, G) or photoreceptors (H, I)
from flies at 0 h of pupal development. Eye structures are labeled as
follows: ed, eye disc; os, optic stalk; ol, optic lobe.
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the nonphotoreceptor bristle, pigment, and cone cells (Hay
et al., 1997).
Overexpression of full-length DSF posterior to the fur-
row, using GMR-GAL4, results in a high level of pharate
adult mortality, likely the result of driver expression out-
side of the developing eye (Fig. 4G). In the eyes of surviving
adults, DSF misexpression substantially alters patterning of
pigment and bristle cells, and results in ommatidial disor-
ganization (Fig. 4I), but does not grossly alter the number of
developing photoreceptor cells (K. D. Finley and M. McKe-
own, unpublished results). Small necrotic patches in the
medial anterior portion of the eye, near the base of the
antenna, are frequently observed (Fig. 4I, arrow). Five full-
length DSF insertions were tested; all gave similarly strong
effects on viability and eye development (Figs. 4G and 4I).
In contrast to UAS-F-DSFFL, for each of three individual
lines of UAS-VP16-DSFFL, GMR-GAL4-driven expression re-
sults in excellent viability (Fig. 4G). The severity of the eye
phenotypes in the adults is also significantly improved. VP16-
DSFFL overexpression results in, at worst, a modest reduction
in pigment and mild disruption of ommatidial organization
(Fig. 4J). The reduction of the UAS-F-DSFFL eye and lethality
phenotypes by addition of VP16 strongly argues that a major
component of the GMR-driven mortality and mispatterning
in the eye results from repression by DSF.
Truncated DSF Proteins with Repressive Domains
Generate DSF Phenotypes
The evidence with the dpp-GAL4 and GMR-GAL4 driv-
ers expressing DSF or VP16-DSF strongly suggests that a
wide array of DSF misexpression phenotypes result from
repression of gene expression. This allows us to test
whether identified repressive domains of DSF can act inde-
pendently of each other in vivo. In particular, we have
examined the hinge deletion mutant, F-DSF172–322, which
lacks much of RF2, but maintains the LBD, and F-DSF1–243,
which lacks the LBD, but retains RF2. When driven by
either dpp-GAL4 or GMR-GAL4, these yield phenotypes
similar to the DSF phenotypes (Figs. 4D, 4E, 4G, 4K, and
4L). This indicates in vivo repressive function for both RF2
and the LBD.
Site-specific DNA binding is also required for DSF’s in
vivo functions. Previously, we observed that the null dsf7
mutation produces a DNA-binding-deficient DSF protein
(Fig. 3D), indicating that DSF’s native activity requires
DNA binding. Similarly, UAS-F-DSFLBD, which lacks DSF’s
DBD and hinge, produces no discernible phenotype with
any of the GAL4 drivers listed in Table 1, nor does UAS-
GAL4-DSFHL, in which DSF’s DBD has been replaced by
that of GAL4 (data not shown).
In Vivo Repression through DSF’s Hinge and LBD
A direct in vivo test of DSF’s repressive capacity requires
a way to direct DSF’s potential repressing or activating
domains to known transcriptional targets, while avoiding
the previously observed lethal effects of ectopic DSF expres-
sion. We achieved this by replacing DSF’s DBD with that of
GAL4. The resulting chimeric protein, GAL4-DSFHL (con-
taining DSF’s Hinge plus LBD, or amino acids 172–693),
strongly represses GAL4-dependent reporters in mamma-
lian cells, while the UAS-GAL4-DSFHL transgenic construct
displays no discernible morphological or toxic effects when
driven by any of the enhancer-GAL4 lines listed in Table 1
(data not shown). Similar constructs have been used to
analyze ligand-dependent and -independent transcriptional
properties of other Drosophila and mammalian nuclear
receptors in culture and in vivo (Solomin et al., 1998; Mata
De Urquiza et al., 1999).
Our target gene for regulation is UAS-GFP. To drive its
expression, then assay repression by a coexpressed UAS-
GAL4-DSFHL, we used dsf1.8-GAL4, which expresses GAL4
under control of the native 1.8-kb dsf enhancer (Finley et
al., 1998). This allows analysis in cells that would normally
express DSF. Control levels of GFP are assayed in crosses
receiving the dsf1.8-GAL4, UAS-GFP, and a neutral UAS-
driven transgene such as UAS-F-DSFLBD, which encodes a
DSF repressive domain but lacks a DNA-binding domain
(Fig. 5A). In experimental crosses, the neutral transgene is
replaced by UAS-GAL4-DSFHL, and levels of expression of
GFP in control and experimental animals are compared. If
the repressive domains of DSF mapped in culture also
repress in vivo, we expect to see decreased levels of GFP in
experimental animals. Note that this coupled expression/
reporter system could underestimate the repressive power
of DSF, as GAL4-DSFHL will repress its own expression, as
well as that of GFP.
GAL4-DSFHL represses quite strongly in salivary glands,
in both third instar larvae (Figs. 5B and 5C) and early pupae
(not shown). Substantial repression is also observed in
neurons of the third instar larval brain and ventral nerve
cord (Figs. 5D and 5E). In early pupae, repression in the
ventral nerve cord is again evident (Figs. 5F and 5G), as is
significant loss of GFP activity in developing photorecep-
tors (Figs. 5H and 5I). This is most readily apparent in
more-developed photoreceptor clusters (on the right, or
posterior edge, of the eye discs in Figs. 5H and 5I), as well as
in their axonal projections along the optic stalk and into the
optic lobes of the brain. These results show that at least one
function of DSF in its normal expression pattern is tran-
scriptional repression. Repression is not limited to cells
which normally express DSF, however, since similar results
are observed when other GAL4 drivers, such as ap-GAL4,
427-GAL4, and GMR-GAL4, are used (data not shown).
DISCUSSION
Results presented in this paper reveal the DNA-binding
and intrinsic regulatory capacities of the DSF nuclear recep-
tor. These functions are likely to be key components of the
mechanism by which DSF functions in patterning the
sex-specific Drosophila nervous system and wild-type
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sexual behavior. Examination of DSF’s DNA-binding and
transcriptional-regulatory properties reveals that DSF acts
as a sequence-specific transcriptional repressor, both in
vitro and in vivo. DSF recognizes an atypical core DNA
binding site, AAGTCA, with additional preferred sequences
lying 3 to this site (Figs. 1A and 1B). While DSF appears to
dimerize on a DR2 site (Fig. 1C), it binds other AAGTCA-
containing sites as a monomer (Fig. 1A). DSF represses
transcription through these sites when cotransfected into
mammalian cells (Fig. 1E). One interesting property of DSF,
however, which distinguishes it from other similar nuclear
receptors such as dTLL, is the apparent ability of DSF’s
356-amino-acid hinge region to substantially reduce the
overall amount of DNA binding DSF can achieve, at least in
vitro (Fig. 2).
In vivo, phenotypes resulting from ectopic expression of
DSF in larval and pupal tissues appear to result primarily
from repression of other genes (Table 1). Specifically, misex-
pression of DSF produces profound developmental disrup-
tion that depends on both the DSF DBD and mapped
repressive domains. Conversion of DSF to an activator, by
fusion with the VP16 activation domain, blocks many of
these effects (Table 1, Fig. 4). When a dual expression/
reporter system designed to assess repressive activity is
employed in vivo, DSF’s hinge and LBD regions function as
powerful repressive domains, in cells that normally express
the dsf gene (Fig. 5), and outside of the normal DSF domain
(data not shown).
Nuclear receptors (NRs) generally function as constitu-
tive transcriptional repressors, except under the special
condition of ligand-dependent activation (Mangelsdorf and
Evans, 1995; Kliewer et al., 1999). Our work in transiently
transfected mammalian cells demonstrates that DSF is a
repressor in the absence of ligand, like most NRs (Figs. 1
and 2). Consistent with this, many of the repressive pheno-
types when DSF is ectopically expressed appear to result
from repression by DSF (Table 1, Fig. 4). These experiments
do not rule out the possible function of an activating ligand,
present at some time or place during misexpression, but do
suggest a larger contribution of repression to the phenotype.
A set of experiments designed to test directly the ability
of DSF’s hinge and LBD regions to repress a strongly
activated promoter in vivo reveals substantial repressive
capacity (Fig. 5). We note, however, that these experiments
are designed to test for repression and are not optimized to
assess activation. An alternative set of experiments de-
signed to look for activation of an inactive promoter,
perhaps at low levels and in a limited time period or
number of cells, is in progress.
Given that ectopic dTLL and cTLX phenotypically re-
semble ectopic DSF expression using multiple GAL4 driv-
ers (J.L.P. and M.M., unpublished data), it is noteworthy
that while universally repressive in mammalian tissue
culture (J.L.P., M.M., unpublished data), dTLL appears to
act genetically as both an activator and a repressor in
Drosophila. Clearly, dTLL appears to repress some of its
presumed in vivo targets, including knirps and Kru¨ppel
(Steingrimsson et al., 1991; Hoch et al., 1992). But dTLL is
also inferred to function as an activator of some target
genes, such as hunchback and brachyenteron, although this
has not been shown to occur directly (Steingrimsson et al.,
1991; Singer et al., 1996). As for TLX, it appears to act as a
repressor in the developing chick retina (Yu et al., 2000). It
remains formally possible that, despite the lack of evidence
currently available, within the narrow spatial and temporal
window in which DSF is naturally expressed, DSF could
become an activator.
What Is the Functional Significance of DSF’s
Hinge?
A striking characteristic of DSF is the length of the hinge
region. Our results demonstrate the presence of both DBD
inhibition and transcriptional repression domains within
this hinge, suggesting a possible role in functional regula-
tion. Conservation of extended regions of this hinge in D.
virilis DSF also suggests conservation of function. Full-
length DSF binds poorly to AAGTCA sites in vitro, relative
to the robust binding displayed by DSF’s isolated DBD (Fig.
2A). This suggests the possibility that DSF’s DNA binding
could be modulated intramolecularly. Biologically, an at-
tractive hypothesis is that this DBD-inhibiting region could
be a target for factors regulating DSF function.
Consistent with this theory, Western blot analysis of DSF
protein ectopically expressed in Drosophila reveals that
DSF is modified in vivo when misexpressed (data not
shown). The small change in mobility is consistent with a
low molecular weight modification such as phosphoryla-
tion. Note that the hinge includes a potential MAP kinase
sequence (PSNSPP, amino acids 354–359) almost identical
to a functionally critical site in the hinge of the SF-1 nuclear
receptor (PYASPP), serine phosphorylation of which un-
masks SF-1’s activation domain (Hammer et al., 1999). The
prolines and downstream serine in this site are conserved
between D. melanogaster and D. virilis DSF proteins (Fig.
3B; PSNSPP in D. melanogaster DSF, PSASPP in D. virilis
DSF). Experiments currently underway will examine the
observed modification in greater detail. This raises the
possibility that a conformational change in DSF, induced by
events such as sex-specific ligand binding, sex-specific
phosphorylation, or both could alter DSF activity, perhaps
contributing to the dsf mutation’s sex-specific phenotypes.
DSF may also require a cofactor(s), sex-specific or not, for
maximal in vivo DNA binding. While DSF does not appear
to heterodimerize with any factor we have tested, genetic
screens currently in progress could reveal such partners.
What Genes Does DSF Regulate?
Given that our evidence suggests that DSF activity in-
cludes transcriptional repression, at least a portion of dsf
loss-of-function phenotypes could be due to loss of repres-
sion of DSF target genes. As for the identity of these target
genes, we note the similarity of the in vitro DNA-binding
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specificity, repression, and ectopic expression phenotypes
of DSF, dTLL, and cTLX. Since several putative targets of
dTLL have been identified, it is possible that DSF targets
may overlap significantly with those of dTLL, at least in
those cells expressing DSF. We are currently directly exam-
ining this possibility.
The data presented herein provide a framework for better
understanding of DSF function, and by extension, molecu-
lar patterning of Drosophila sexual behavior. Continued
elucidation of these modulatory pathways will further our
understanding of the genetic control of behavior.
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